Matteo Mancini1,2, Mara Cercignani2,3, Sonia Bonnì4, Silvia Picazio4, Viviana Ponzo4, Maria Concetta Pellicciari4, Elias Casula4, Laura Serra2, Carlo Caltagirone4, Giacomo Koch4,5, and Marco Bozzali2
1University of Rome "Roma Tre", Rome, Italy, 2Neuroimaging Laboratory, Santa Lucia Foundation, Rome, Italy, 3Clinical Imaging Sciences Centre, University of Sussex, Brighton, United Kingdom, 4Non-Invasive Brain Stimulation Unit, Santa Lucia Foundation, Rome, Italy, 5Stroke Unit, Policlinico Tor Vergata, Rome, Italy
Synopsis
We present a double-blind randomized cross-over
clinical study that aims to investigate the efficacy of two weeks of repetitive
transcranial magnetic stimulation (TMS) in modulating cognitive performances in
patients with mild cognitive impairment (MCI) and to characterize in vivo brain
connectivity changes in MCI patients after rTMS. We used a multi-modal approach
based on behavioural tests, TMS-EEG, DWI and fMRI. The behavioural and
neurophysiological results support the role of medial parietal region in memory
process. Moreover, our findings suggest that TMS may be a potential effective
strategy in treatment of MCI patients for whom, currently, there is no
available therapy.
Purpose
Mild cognitive
impairment (MCI) has been identified as the earliest condition associated with
an increased risk for developing Alzheimer's Disease (AD). The most common
clinical presentation of MCI is associated with memory loss as the predominant
symptom (amnesic MCI). Previous studies have shown that MCI is characterized by
altered connectivity in the posterior part of the Default Mode Network (DMN)1.
The application of transcranial magnetic stimulation (TMS) over the precuneus (PC)
was shown to be associated with an improvement in episodic memory suggesting a
direct implication of the PC in successful context-dependent retrieval2.
The present double-blind randomized cross-over clinical study aims to investigate
the efficacy of two weeks of repetitive TMS in modulating cognitive
performances in patients with MCI and to characterize in vivo brain
connectivity changes in MCI patients after rTMS.Methods
Fourteen MCI patients were enrolled in the
study. TMS was applied over PC at 20 Hz, in a 10-session course over two weeks
in a sham-controlled crossover design (fig. 1). Subjects were randomly assigned
to real stimulation or sham stimulation. A 2-week washout period was applied
following which subjects were crossed over to the alternate treatment for additional
two weeks. Neuropsychological tests and TMS-EEG co-registrations were obtained
at baseline and after two weeks of treatment for real and sham condition. Eight
out of 14 patients also had MRI, including T1-weighted volumes, resting state
fMRI (TR=2.08 s; TE=30 ms) and diffusion-weighted imaging (DWI, (TR=7000 ms,
TE=85 ms, 61 directions, b-factor=1000 smm-2) at baseline and
follow-up. In order to ensure targeting of the PC, cortical sources were estimated
from the TMS-EEG data and the response to the stimulation of the PC was tested
against the baseline using a t-test. To evaluate the behavioural effects of
rTMS treatment, a modified version of Alzheimer Disease Cooperative Study
Preclinical Alzheimer Cognitive Composite (ADCS-PACC)3 was adopted:
the ADCS-PACC combines tests that assess episodic memory, timed executive
function, and global cognition. The effects of the treatment were evaluated also
using the TMS-evoked responses over each stimulation site with a spatio-temporal-domain
analysis to assess cortical excitability at global level. T1 volumes were
pre-processed using FreeSurfer and parcellated using the Desikan-Killiany
atlas. Diffusion images were co-registered to mean b0 volume in order to
minimize distortions and then processed using tensor fitting and deterministic
tractography by means of Diffusion Toolkit. The reconstructed streamlines were
linearly co-registered to the anatomical space and for each subject the number
of streamlines between each couple of parcellated regions was counted and
recorder in an adjacency matrix. Functional data were pre-processed using FSL
and AROMA4 for a robust reduction of movement artifacts, and then
co-registered to the anatomical space. For each region, the average BOLD time-series
was computed and for each pair of regions the Pearson correlation between the
averaged time-series was computed. Appropriate thresholding was used for both
structural and functional connectivity5. We then assessed changes within
the DMN and across-networks. For the former, we compared functional
connectivity pre-post treatment differences for the DMN regions6,
using the degree as a connectivity measure and the sign test for assessing
significance. For the latter, anatomically-constrained functional connectivity7
was estimated evaluating functional connectivity in presence of structural
connections estimated by DWI. Differences were assessed using network-based
statistics (NBS)8 using two different thresholds.Results
The patients demonstrated an improvement in
episodic memory performance following real stimulation compared to sham
stimulation (p<0.05, fig. 2). Source analysis showed a significant response
of the PC compared to baseline (p<0.01) and the whole treatment produced significant
increase of TMS evoked activity over a specific time window (60 ms after TMS)
over a fronto-parietal cluster of electrodes (p<0.01, fig. 3). No
significant difference was observed comparing pre-post degrees differences for
the regions of the DMN. Anatomically-constrained connectivity has instead
revealed decreased connectivity in a specific fronto-parietal network (t=3.1,
p=0.0051, fig. 4a; t=2.1, p=0.0192, fig. 4b) when comparing pre-post sham and
effective stimulation conditions.Discussion
The behavioural and neurophysiological results
support the role of medial parietal region in memory process. Moreover, the MRI
results indicate decreasing local connectivity beyond the DMN, an effect that
potentially compensates the AD-related increased local connectivity9,10.Conclusion
Used together, TMS, structural and fMRI
techniques, offer a unique opportunity to assess in vivo functional and
structural brain connectivity in healthy as well as in diseased brains. These
findings also suggest that TMS may be a potential effective strategy in
treatment of MCI patients for whom, currently, there is no available therapy.Acknowledgements
This study was funded by the Italian Ministry of Health (RF10.047).
References
1. Bozzali et al. Damage
to the cingulum contributes to Alzheimer's disease pathophysiology by
deafferentation mechanism. Human Brain Mapping 2011, 33(6): 1295-308; 2. Bonnì
et al. TMS evidence for a selective role of the precuneus in source memory
retrieval. Behavioural Brain Research 2015, 282: 70-75; 3. Donohue et al. The
preclinical Alzheimer cognitive composite: measuring amyloid-related decline.
JAMA Neurol 2014, 71(8): 961-70; 4. Pruim et al. ICA-AROMA: A robust ICA-based
strategy for removing motion artifacts from fMRI data. Neuroimage 2015, 112: 267-77;
5. Fallani et al. Graph analysis of functional brain networks: practical issues
in translational neuroscience. Phil Trans R Soc B 2014, 369: 20130521; 6. Power
et al. Functional network organization of the human brain. Neuron 2011, 72(4):
665-78; 7. Liégeois et al. Cerebral functional connectivity periodically
(de)synchronizes with anatomical constraints. Brain Structure and Function
2016, 221(6): 2985-97; 8. Zalesky et al., Network-based statistic: identifying
differences in brain networks. Neuroimage 2010, 53(4): 1197-207; 9. Jones et
al. Cascading network failure across the Alzheimer’s disease spectrum. Brain
2016, 139(2): 547-62; 10. Zhang et al. Enhanced resting-state functional
connectivity between core memory-task activation peaks is associated with
memory impairment in MCI. Neurobiology of Aging 2016, 45: 43-49.